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Abstract
Background: Endocrine disruptors (EDs) and their broad range of potential adverse effects in humans and other
animals have been a concern for nearly two decades. Many putative EDs are widely used in commercial products
regulated by the Food and Drug Administration (FDA) such as food packaging materials, ingredients of cosmetics,
medical and dental devices, and drugs. The Endocrine Disruptor Knowledge Base (EDKB) project was initiated in
the mid 1990’s by the FDA as a resource for the study of EDs. The EDKB database, a component of the project,
contains data across multiple assay types for chemicals across a broad structural diversity. This paper demonstrates
the utility of EDKB database, an integral part of the EDKB project, for understanding and prioritizing EDs for testing.
Results: The EDKB database currently contains 3,257 records of over 1,800 EDs from different assays including
estrogen receptor binding, androgen receptor binding, uterotropic activity, cell proliferation, and reporter gene
assays. Information for each compound such as chemical structure, assay type, potency, etc. is organized to enable
efficient searching. A user-friendly interface provides rapid navigation, Boolean searches on EDs, and both
spreadsheet and graphical displays for viewing results. The search engine implemented in the EDKB database
enables searching by one or more of the following fields: chemical structure (including exact search and similarity
search), name, molecular formula, CAS registration number, experiment source, molecular weight, etc. The data can
be cross-linked to other publicly available and related databases including TOXNET, Cactus, ChemIDplus, ChemACX,
Chem Finder, and NCI DTP.
Conclusion: The EDKB database enables scientists and regulatory reviewers to quickly access ED data from
multiple assays for specific or similar compounds. The data have been used to categorize chemicals according to
potential risks for endocrine activity, thus providing a basis for prioritizing chemicals for more definitive but
expensive testing. The EDKB database is publicly available and can be found online at http://edkb.fda.gov/webstart/
edkb/index.html.
Disclaimer: The views presented in this article do not necessarily reflect those of the US Food and Drug Administration.
Background
Evidence that certain man-made chemicals have the
ability to disrupt the endocrine systems of vertebrates
by mimicking endogenous hormones has sparked
intense international scientific discussion and debate [1].
The growing national concern resulted in legislation,
including the amendments of the Safe Drinking Water
Act and the Federal Food, Drug and Cosmetic Act [2]
and passage of the 1996 Food Quality Protection Act
mandating that the Environmental Protection Agency
(EPA) develop a screening program for endocrine dis-
ruptors (EDs) [3]. Under this requirement, at least
58,000 existing chemicals would be experimentally eval-
uated for their potential to disrupt activities in the estro-
gen, androgen, and thyroid hormone systems [4]. Some
of the chemicals were associated with products
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packaging, phytoestrogens, food additives, pharmaceuti-
cals, cosmetics, etc [5]. A battery of in vitro and short-
term in vivo screening assays would be used to provide
guidance for subsequent longer term, more definitive in
vivo tests for toxicity [3].
Endocrine disruption is associated with interference
caused by exogenous chemicals of the normal produc-
tion, release, transport, metabolism, binding, action, or
elimination of natural hormones in the body responsible
for the maintenance of homeostasis and regulation of
developmental processes [6,7]. Effects of EDs are known
to occur in multiple endocrine axes such as estrogen,
androgen, thyroid hormone, prolactic, and insulin sys-
tems. The putative adverse effects of EDs are wide ran-
ging and the mechanisms of action are concomitantly
diverse; many assay protocols have been used to mea-
sure their effects [8-10]. A vast body of literature has
accumulated to demonstrate that suspected and known
EDs are structurally diverse with many acting via bind-
ing to hormone protein receptors [11,12]. The multidi-
mensional aspects of the science of EDs amplify the
importance of a corresponding knowledge base such as
the one discussed in this manuscript aggregating exist-
ing knowledge for the research and regulatory
communities.
In the fall of 1996, a National Science and Technology
Council [13] report on EDs identified a need for new
databases and information systems. The report called
for “a compilation of the results of chemicals in various
short-term screening tests and in vivo assays to assist in
the evaluation of their sensitivity, specificity and general
predictiveness.” Although these assays and tests have
been performed many times by different procedures in
many labs, the experimental results were scattered
throughout the literature, making it difficult for
researchers to find, compare, and evaluate relevant data
and the assay protocols that generated the data. The
Endocrine Disruptor Knowledge Base (EDKB) project,
developed by the FDA’s National Center for Toxicologi-
cal Research (NCTR), arose from a necessity for new
information systems focused on aggregating knowledge
of EDs with experimental results relevant to estrogenic,
androgenic, and other ED data in one accessible loca-
tion. This collection of experimental results from diverse
assays enables comparative analysis for a wide variety of
chemicals and serves a basis for developing in silico pre-
dictive models for prioritizing potential EDs for further
study.
Online chemical toxicity databases with the capabil-
ities of searching both chemical structure and biological
activities are urgently needed for the regulatory and
research community [14-16]. Two large efforts, TOX-
NET (TOXicology Data NETwork) and Tox21 [17-21],
have been developed by government agencies focused
on public database and data access. TOXNET provides
free access and easy searching in a cluster of databases
covering toxicology, hazardous chemicals, environmental
health, and toxic releases [22]. The ChemIDplus data-
base in TOXNET offers structural search capabilities.
Tox21 is expected to deliver biological activity profiles
that might enable predictive assays of in vivo toxicities
for the thousands of poorly studied substances of con-
cern to regulatory authorities in the United States and
other countries [23]. While these two large programs
will provide rich information for chemical toxicity, they
do not provide domain specific knowledge for EDs.
The EDKB project was initiated as a research asset to
help address regulatory concerns on EDs. The online
database provides contains chemicals spanning a wide
range of FDA-regulated products including drugs, food,
and cosmetics as well as EPA-regulated products such
as pesticides, chemical waste, and toxic metals. The
EDKB database has been used extensively for over a
decade to help identify EDs, develop predictive toxicol-
ogy models, and prioritize chemicals for laborious,
expensive testing [4,5,12,24-26].
Construction and content
The EDKB database is a client-server application con-
sisting of a Java front-end and an ORACLE database
serving as the data repository. The client application
runs on the user’s workstation and allows researchers to
conduct Boolean queries of the relational database and
view the results. The database contains 3,257 records
f o ro v e r1 8 0 0c h e m i c a lc o m p o u n d sa n dw i l lb e
expanded in the future. Many chemicals have data from
several different assays, including data from in-house
competitive binding assays (e.g., NCTR generated bind-
ing assay data for both estrogen and androgen recep-
tors) [27-30]. The curated data are hyperlinked to the
corresponding literature source in query results. Figure
1 displays a data flow model of the EDKB database.
The distribution of the data among different assay
types is shown in Table 1. Endpoints were often mea-
sured as a relative activity to a reference chemical. For
example, the reference chemical for estrogenic activity,
17b-Estradiol, is defined to have an activity value of 2
(log10100=2), while R1881 is a reference chemical with
the defined activity value of 2 (log10100=2) for androgen
receptor binding. Consequently, estrogen activity values
for the EDKB chemicals range from 2.94 (strongest) to
-4.5 (weakest) while androgen activity values range from
3.18 to -3.56; each covers a range of 7 orders of magni-
tude. Note that in the EDKB database, the activity value
-10000 is assigned to inactive chemicals; additionally,
chemicals that have very weak binding may be assigned
placeholder values from -5 to -10000 [27,28].
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Page 2 of 7The EDKB database has been populated with assay
data from rat, mouse, and human and contains a broad
chemical structure diversity. Table 2 classifies the data
based on chemical structure category. Categories that
contain more active records than inactive records are
bolded, such as phytoestrogens, diethylstilbestrol (DES)-
like chemicals, steroidal chemicals, etc.
Utility
The EDKB database has been online since 1997 and is
still actively used by government, academic, and private
sectors. It is free to use and publicly available on the
internet at http://edkb.fda.gov/webstart/edkb/index.html.
Six main components of the interface are labeled in
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Figure 1 Data flowchart for the EDKB database In house data and literature results are stored in an ORACLE database, which can be
communicated with using the interface. The user interface can link chemical knowledge in any one of its components to the other two.
Table 1 Summary of the data contained in the EDKB database
Assay type Number of records Standard chemical to be compared Endpoint Log (Activity) Range
Estrogen Receptor Binding 616 Estradiol (2.0) *RBA From 2.94 to -4.5
Androgen Receptor Binding 230 R1881 (2.0) RBA From 3.18 to -3.56
Uterotropic 1707 Estradiol (2.0) **RP From 3.93 to -3.44
Cell proliferation 160 Estradiol (2.0) ***RPP From 3.0 to -4.22
Reporter gene 544 Estradiol (2.0) RP From 2.18 to -5.38
A summary of the distribution of data, standard chemicals to be compared, endpoints, and activity ranges.
The values in parentheses are log activity for a standard chemical
* RBA: Relative Binding Affinity
** RP: Relative Potency
*** RPP: Relative Proliferation Potency
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table listing the chemical compound data. The spread-
sheet format allows easy browsing of the entire database
and supports column-specific sorting, searching, and fil-
tering options. Each record contains a variety of informa-
tion including name, assay type, CAS number, chemical
formula, experiment source, molecular weight, etc.
2. The Graphic Activity Profile (GAP) shows the rela-
tive potency of compounds on a log base 10 scale. Com-
pounds observed in multiple experiments may exhibit a
range rather than a single point. The GAP table plots all
data entries that are currently visible in the spreadsheet
view (i.e., not hidden by filters).
3. The search panel provides a simple way to find
desired chemical compounds in the EDKB database.
The chemical structure can be used to locate com-
pounds that are similar to or are substructures of the
selected compound. The database can also be searched
by compound name, chemical formula, various molecu-
lar IDs, and assay type. Searching within previous results
is supported as well.
4. The interface includes a graphical display of the
chemical structure of any compound individually
selected in the table. The Edit button opens the Mole-
cule Sketcher, which can be used to manually edit the
chemical structure or to change the notation (e.g., mak-
ing H atoms explicit). After editing or creating a chemi-
cal structure, a substructure or similarity search can be
performed.
5. Compounds in the EDKB database can be directly
linked to public online databases including TOXNET,
Cactus, NCI DTP, etc. Using the “Link To” feature will
open the user’s web browser and automatically search
the selected website based on the appropriate identifiers,
which can save significant amounts of time.
6. A detailed summary of any individual compound
c a nb eo p e n e di nan e ww i n d o wb yu s i n gt h e“More
Info” button. This functionality is useful to summarize
all the available information for this chemical, such as
synonyms, relevant experiment details, and references.
Additionally, each experiment involving the compound
has a summary page that can be accessed from here.
Results and discussion
The EDKB database has users from government, acade-
mia, and private sectors throughout the world. Recent
user statistics, shown in Figure 3, indicate that the data-
base has been steadily accessed by a significant number
of users over the past five years. We will show three use
cases for the EDKB database to assess the estrogenic
activity potential of three interesting chemicals from
among 58,000 compounds that the EPA chose for
screening for ED activity [4]: genistein, L-ascorbic acid,
and 4,4’,4”-ethylidynetrisphenol. See additional file 1 for
the data used to perform the analysis in this section.
Genistein, also known as 5,7,4’-trihydroxyisoflavone, is a
phytochemical that can be found in soybean-derived food
products. Searching for genistein by compound name
returned 14 records in the EDKB database, all of which
showed estrogenic activity as compared to the standard
endogenous sex hormone 17b-estradial. The EDKB data-
base shows that genistein has a relatively high binding affi-
nity for the estrogen receptor (ER) nuclear protein.
However, genistein results have considerably lower end-
point values relative to 17b-estradial in reporter gene assays
measuring ER transcription factor activity, and lower still
relative values in in vitro assays of cancer cell proliferation.
In uterotrophic assays measuring uterine weight gain, genis-
tein is some 100,000 fold less potent than 17b-estradial.
Based on this data alone, genistein could be a potent ED
Table 2 Structure categories in the EDKB database
Structure categories Number of records Active /in active Number of chemicals
Benzene 12 0/12 7
DDT 164 101/63 33
DES 109 95/14 22
Flutamide 8 5/3 5
NoRing 11 1/10 8
PAH 6 0/6 3
PCB 45 37/8 12
Pesticide 92 29/63 20
Phenol 110 80/30 35
Phthalate 40 14/26 8
Phytoestrogen 147 110/37 46
Siloxane 6 3/3 3
Steroid 282 194/88 58
Other 2225 358/1867 1610
A display of the number of records, chemicals, and active/inactive spread for each structure category.
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Page 4 of 7Figure 2 User interface for the EDKB database Six key components of the user interface are numbered and described in the manuscript.
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Figure 3 User statistics of the EDKB database Bar graph displaying the number of times the EDKB database was accessed per half year
between 2005 and 2009.
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Page 5 of 7that competitively binds ER in a similar manner to 17b-
estradial. It is possible that genistein mimics the sex hor-
mone sufficiently to cause down regulation of ER, resulting
in suppression of ER regulated mRNA. Thus, genistein is
likely an ED and substantial further testing is warranted.
L-ascorbic acid, also known as Vitamin C, is an essen-
tial nutrient for humans and certain other animal spe-
cies. The ED data for this chemical is not available in
the EDKB. Thus, we conducted the structure similarity
search by comparing its chemical structure with the
compounds in the EDKB. We found that the 10 chemi-
cals (occurring in 14 records) with the most similar
structures (40 to 50% similarity) have all been measured
as inactive in estrogenicity assays. Accordingly, L-ascor-
bic acid could be assigned a low priority for further test-
ing as a potential endocrine disrupting chemical.
The chemical 4,4’,4”-ethylidynetrisphenol is used as a
cross linking or branching agent in various polymer appli-
cations, such as use in polycarbonates, epoxies, adhesives,
coatings, and antioxidants [31]. While no name matches
were found for this chemical in the EDKB, the same struc-
ture search strategy mentioned above was applied, return-
ing four compounds with a similarity rating of 100% as
well as several others with very high similarity ratings.
Among the top ten most similar compounds, a majority of
the 45 recorded instances show estrogenic activity. These
results indicate that 4,4’,4”-ethylidynetrisphenol is a poten-
tial ED and could be considered for further testing.
These use cases illustrate that once the database is
established, queries enable knowledge-based conclusions
that can lead to research hypotheses and questions to be
posed for regulatory decision-making.
Conclusion
In an age of information technology, it is crucial to have a
database containing specific toxicology data and structure
search capabilities. The EDKB database fulfills this role and
is valuable in extending predictive systems to real-world reg-
ulatory implementations. It is freely available on the web and
assists researchers in accessing and interpreting ED data.
Additional material
Additional file 1: EDKB database results for 3 specific chemicalsThe
first table in the file gives an overview of the 3 chemicals: genistein, L-
ascorbic acid, and 4,4’,4”-ethylidynetrisphenol. The second displays the
results when the EDKB database was searched by compound name for
genistein. The third and forth display results using the compound
structure similarity for L-ascorbic acid and 4,4’,4”-ethylidynetrisphenol,
respectively.
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